🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
1. Primary (main): Comparison between goal directed therapy and PCO2 ga...
Status
Completed
Location
South Valley University
Start Date
2019-11-10
Trial ID
NCT04792242
Treatments Being Tested
The purpose of this study is to investigate the clinical efficacy of high-d...
Status
Unknown
Location
Department of Hematology, Nagoya University Graduate School of Medicine
Start Date
2002-09
Trial ID
NCT00131027
This study aims at comparing manual function outcomes between the standard ...
Status
Recruiting
Location
Johns Hopkin
Start Date
2023-09-28
Trial ID
NCT05929027
Treatments Being Tested
QUESTIONS AND OBJECTIVES OF ALL-MB-2008 STUDY 1. Whether the early PEG-asp...
Status
Unknown
Location
Republican Research and Practical Center of Radiation Medicine
Start Date
2008-02
Trial ID
NCT01953770
The objective of this study is 1) to study the acute and chronic effect of ...
Status
Not Yet Recruiting
Location
Cristina Roldán Jiménez
Start Date
2024-08
Trial ID
NCT06113627
Treatments Being Tested
Physical activity (PA) is essential for the prevention and treatment of chr...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-09-01
Trial ID
NCT06440369
Treatments Being Tested
Beta blockers have been shown to decrease the risk of intraoperative cardia...
Status
Withdrawn
Location
Community Regional Medical Center
Start Date
2011-03
Trial ID
NCT01330654
Treatments Being Tested
The average age of patients with sepsis has increased in recent years in pa...
Status
Completed
Location
Hospital General de Granollers
Start Date
2018-01-01
Trial ID
NCT06354452
The fluoropyrimidines 5-fluorouracil (5FU) and capecitabine (Cp) are among ...
Status
Completed
Location
Inselspital
Start Date
2012-10
Trial ID
NCT01641458
To evaluate the safety and efficacy of PD-1 immune checkpoint inhibitor com...
Status
Unknown
Location
Yanqun Xiang
Start Date
2022-03-12
Trial ID
NCT05229315
Treatments Being Tested